Crandell Keith's Form 4 filing
Codiak BioSciences, Inc.CDAK · filed Sep 15, 2022
- Accession no.
- 0001062993-22-019586
- Filed
- Sep 15, 2022, 6:53 PM ET
- Trade date
- Sep 13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $7.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crandell KeithCIK 0001219039 | 10% Owner |
| Nelsen RobertCIK 0001219042 | 10% Owner |
| Bybee ClintonCIK 0001219043 | 10% Owner |
| ARCH Venture Fund VIII, L.P.CIK 0001605598 | 10% Owner |
| ARCH Venture Partners VIII, LLCCIK 0001616165 | 10% Owner |
| ARCH Venture Partners VIII, L.P.CIK 0001616176 | 10% Owner |
| ARCH Venture Fund VIII Overage, L.P.CIK 0001617237 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Common Sotck | PPurchaseAcquired | +5,000,000 | $1.50 | +$7,500,000 | 8,854,098 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Common Stock | PPurchaseAcquired | +5,000,000 | –F1 | – | 5,000,000 | Direct | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares purchased in a private investment in public equity transaction on September 13, 2022. Accompanying the Common Stock is one Series A Warrant to purchase one share of common stock at an exercise price of $1.875 per share.
Referenced by the price of 1 transaction in Table II.